statistiche ricercatore

Continente	#
AS - Asia	563
NA - Nord America	542
EU - Europa	370
SA - Sud America	75
AF - Africa	19
Continente sconosciuto - Info sul continente non disponibili	1
Totale	1.570

Nazione	#
US - Stati Uniti d'America	518
SG - Singapore	182
CN - Cina	172
IT - Italia	105
BR - Brasile	64
GB - Regno Unito	61
HK - Hong Kong	61
BD - Bangladesh	48
DE - Germania	42
VN - Vietnam	39
RU - Federazione Russa	35
SE - Svezia	30
NL - Olanda	25
FR - Francia	22
IN - India	19
CA - Canada	14
DK - Danimarca	8
FI - Finlandia	8
IE - Irlanda	8
KR - Corea	8
CI - Costa d'Avorio	6
EG - Egitto	6
ES - Italia	6
AR - Argentina	4
ID - Indonesia	4
IQ - Iraq	4
JP - Giappone	4
MX - Messico	4
UA - Ucraina	4
AT - Austria	3
PL - Polonia	3
SA - Arabia Saudita	3
SN - Senegal	3
TR - Turchia	3
UZ - Uzbekistan	3
AZ - Azerbaigian	2
CH - Svizzera	2
CO - Colombia	2
CY - Cipro	2
LT - Lituania	2
NP - Nepal	2
TN - Tunisia	2
AO - Angola	1
BE - Belgio	1
BY - Bielorussia	1
CR - Costa Rica	1
DZ - Algeria	1
EC - Ecuador	1
GT - Guatemala	1
HN - Honduras	1
JM - Giamaica	1
KG - Kirghizistan	1
LA - Repubblica Popolare Democratica del Laos	1
LU - Lussemburgo	1
LV - Lettonia	1
MT - Malta	1
PE - Perù	1
PH - Filippine	1
PK - Pakistan	1
PR - Porto Rico	1
PS - Palestinian Territory	1
PT - Portogallo	1
PY - Paraguay	1
SV - El Salvador	1
TH - Thailandia	1
TW - Taiwan	1
UY - Uruguay	1
VE - Venezuela	1
XK - ???statistics.table.value.countryCode.XK???	1
Totale	1.570

Nome	#
Use of oral anticoagulant drugs in older patients with atrial fibrillation in internal medicine wards	214
Interaction between lifestyle changes and PNPLA3 genotype in NAFLD patients during the COVID-19 lockdown	211
Progressive splenomegaly and mild thrombocytosis in beta-thalassaemia trait and coexisting hereditary hemochromatosis: possible confounders for a subsequent hematological diagnosis	184
Long-term outcomes and predictive ability of non-invasive scoring systems in patients with non-alcoholic fatty liver disease	154
Evolution of liver fibrosis in diabetic patients with NAFLD in a follow-up study: Hepatoprotective effects of sodium-glucose co-transporter-2 inhibitors	153
Caucasian lean subjects with non-alcoholic fatty liver disease share long-term prognosis of non-lean: time for reappraisal of BMI-driven approach?	128
Presence of Serum Antinuclear Antibodies Does Not Impact Long-Term Outcomes in Nonalcoholic Fatty Liver Disease	122
Procoagulant imbalance is associated with hepatic and vascular complications in patients with MASLD and diabetes. Key role of factor VIII	119
Metabolic comorbidities and male sex influence steatosis in chronic hepatitis C after viral eradication by direct-acting antiviral therapy (DAAs): Evaluation by the controlled attenuation parameter (CAP)	119
MAFLD and NAFLD: is there the need for redefining the risk of cardiovascular disease and mortality?	116
MAFLD definition underestimates the risk to develop HCC in genetically predisposed patients	100
Totale	1.620

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	1	0	0	0	0	0	0	0	0	0	0	0	1
2021/2022	63	2	2	7	4	5	2	2	4	6	6	4	19
2022/2023	110	12	14	9	13	11	17	1	7	18	1	7	0
2023/2024	83	0	8	3	8	33	4	2	1	5	1	6	12
2024/2025	389	15	25	21	25	19	17	25	30	29	40	63	80
2025/2026	845	91	72	111	72	66	40	99	33	63	65	110	23
Totale													1.620

IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca